Skip to content

Clinical trials

Phase 2 Liver Cirrhosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Phase 2 Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20043
20054
20061
20071
20081
20092
20102
20116
20125
20133
20145
20155
20162
20175
20187
20198
20204
20214
20226
20236
202412
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Recruiting15
Terminated14
Unknown status14
Not yet recruiting4
Active, not recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Conatus Pharmaceuticals Inc.5
Gilead Sciences5
Boehringer Ingelheim3
Bristol-Myers Squibb3
Sanofi3
Sun Yat-sen University3
Cumberland Pharmaceuticals2
Hepion Pharmaceuticals, Inc.2
Kiminori Kimura, MD2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis102
Non-alcoholic Fatty Liver Disease22
Fibrosis16
Hepatitis C8
Hypertension, Portal8
Ascites7
Carcinoma, Hepatocellular7
Hepatic Encephalopathy6
Liver Diseases6
Fatty Liver4

Trials

Showing 51 to 75 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.